Crizotinib Exhibits Antitumor Activity by Targeting ALK Signaling not c-MET in Pancreatic Cancer

by Yan, Hong Hua, Jung, Kyung Hee, Son, Mi Kwon, Fang, Zhenghuan, Kim, Soo Jung, Ryu, Ye-Lim, Kim, Juyoung, Kim, Mi-Hyun, Hong, Soon-Sun
Published 2014

HS-173, a Novel PI3K Inhibitor, Attenuates the Activation of Hepatic Stellate Cells in Liver Fibrosis

by Son, Mi Kwon, Ryu, Ye-Lim, Jung, Kyung Hee, Lee, Hyunseung, Lee, Hee Seung, Yan, Hong Hua, Park, Heon Joo, Ryu, Ji-Kan, Suh, Jun–Kyu, Hong, Sungwoo, Hong, Soon-Sun
Published 2013

HS-133, a novel fluorescent phosphatidylinositol 3-kinase inhibitor as a potential imaging and anticancer agent for targeted therapy

by Lee, Ju-Hee, Jung, Kyung Hee, Lee, Hyunseung, Son, Mi Kwon, Yun, Sun-Mi, Ahn, Sung-Hoon, Lee, Kyeong-Ryoon, Lee, Soyoung, Kim, Donghee, Hong, Sungwoo, Hong, Soon-Sun
Published 2014

HS-543 induces apoptosis of Imatinib-resistant chronic myelogenous leukemia with T315I mutation

by Kim, Soo Jung, Jung, Kyung Hee, Yan, Hong Hua, Son, Mi Kwon, Fang, Zhenghuan, Ryu, Ye-Lim, Lee, Hyunseung, Lim, Joo Han, Suh, Jun-Kyu, Kim, JinHee, Lee, Soyoung, Hong, Sungwoo, Hong, Soon-Sun
Published 2014